CD BioGlyco offers end-to-end glycobiology services, from analyzing and synthesizing glycans to modifying them. Their synthetic biology platform is built to help clients in pharma, food, and cosmetics ...
SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results